Back to Journals » Therapeutics and Clinical Risk Management » Volume 14

Levodopa/carbidopa/entacapone versus levodopa/dopa-decarboxyiase inhibitor for the treatment of Parkinson's disease: systematic review, meta-analysis, and economic evaluation
Total article views | Abstract views | HTML views | PDF downloads | Totals | |
---|---|---|---|---|---|
11,982 | Dovepress* | 8,020 | 2,688+ | 1,304 | 10,708 |
PubMed Central* | 0 | 1,274 | 447 | 1,274 | |
Totals | 8,020 | 3,962 | 1,751 | 11,982 | |
*Since 16 April 2018 +Since July 2016 |
View citations on PubMed Central and Google Scholar